Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma

Published:2013-04-26 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Gennatas Spyridon,Stanway Susana J,Thomas Robert,Min Toon,Shah Riyaz,O’Brien Mary ER,Popat Sanjay

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-207.pdf

Reference12 articles.

1. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG: Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer. N Engl J Med Mass Medical Soc. 2010, 363 (18): 1693-1703. 10.1056/NEJMoa1006448.

2. Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA: Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011, 12 (11): 1004-1012. 10.1016/S1470-2045(11)70232-7. Oct

3. Scagliotti G, Stahel RA, Rosell R, Thatcher N, Soria J-C: ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. Eur J Cancer. 2012, 48 (7): 961-973. 10.1016/j.ejca.2012.02.001. May

4. Gandhi L, Janne PA: Crizotinib for ALK-rearranged Non-Small Cell Lung Cancer: a new targeted therapy for a new target. Clin Cancer Res. 2012, 18 (14): 3737-42. 10.1158/1078-0432.CCR-11-2393.

5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S: Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005, 353 (2): 123-132. 10.1056/NEJMoa050753. Jul 14

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib-induced severe bilateral pneumothorax: A case report;Medicine;2024-01-19

2. Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity;Frontiers in Oncology;2023-07-10

3. Pneumothorax during alectinib treatment for a uterine inflammatory myofibroblastic tumor with lung metastasis;Journal of Cancer Research and Practice;2023

4. Post-chemotherapy and targeted therapy imaging of the chest in lung cancer;Clinical Radiology;2022-01

5. Drug-induced pleural diseases;HERALD of North-Western State Medical University named after I.I. Mechnikov;2021-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3